Transfersomes: a novel technique for transdermal drug delivery
Novel drug delivery systems are now a days is creating a new interest in development of drug deliveries. Vesicular drug delivery system is also a part of these novel drug delivery systems. TDDS is the permeability of the skin, it is permeable to small molecules, lipophilic drug and highly impermeable to the macromolecules and hydrophilic drugs. Recent approaches have resulted in design of two vesicular carriers, ethosomes and ultra flexible lipid based elastic vesicles, transferosomes. Transferosomes have recently been introduced, which are capable of transdermal delivery of low as well as high molecular weight drugs. This offers several potential advantages over conventional routes like avoidance of first pass metabolism, predictable and extended duration of activity, minimizing undesirable side effects, utility of short half life drugs, improving physiological and pharmacological response and have been applied to increases the efficiency of the material transfer across the intact skin, by the use of penetration enhancers, iontophoresis, sonophoresis and use of colloidal carriers such as lipid vesicles (liposomes & proliposomes) and non-ionic surfactant vesicles (niosomes & proniosomes). It is suitable for controlled and targeted drug delivery and it can accommodate drug molecules with wide range of solubility. Due to its high deformability it gives better penetration of intact vesicles. They are biocompatible and biodegradable as they are made from natural phospholipids and have high entrapment efficiency. The preparation variables are depending upon the procedure involved for manufacturing of formulation and the preparation procedure was accordingly optimized and validated. Characterization of transferosomes can be done to know the vesicle size, morphology, drug content, entrapment efficiency, penetration ability, occlusion effect, surface charge, in vitro drug release, in vitro skin penetration etc., It increases stability of labile drugs and provides control release. Transferosomes thus differs from such more conventional vesicles primarily by its softer, more deformable, better adjustable artificial membrane.
Keywords: Novel Drug Delivery System, Biocompatible, Characterization, Transferosomes.
2. Barry BW. Breaching the skin’s barrier to drugs. Nat Biotechnol 2004; 22:165-7.
3. Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2005; 2:67-74.
4. Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 2009; 380:72-9.
5. Bhowmik D, Chiranjib V, Chandira M, Jayakar B, Sampath KP. Recent advances in transdermal drug delivery system. Int J Pharm Tech 2010; 2:68-77.
6. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14:101-14.
7. Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008; 60:1638-49.
8. Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta 2009; 1788:2362-73.
9. Crommelin DJ, Eling WM, Steerenberg PA, Nässander UK, Storm G, De Jong WH, et al. Liposomes and immunoliposomes for controlled release or site specific delivery of anti-parasitic drugs and cytostatics. J Control Release 1991; 16:147-54.
10. Yavlovich A, Singh A, Blumenthal R, Puri A. A novel class of photo-triggerable liposomes containing DPPC: DC8, 9PC as vehicles for delivery of doxorubcin to cells. Biochim Biophys Acta 2011; 1808:117-26.
11. Modi CD, Bharadia PD. Transfersomes: A newdominants for transdermal drug delivery. Am J PharmTech Res 2012; 2:71-91.
12. Prajapati ST, Patel CG, Patel CN. Transfersomes: A vesicular carrier system for transdermal drug delivery. Asian J Biochem Pharm Res 2011; 2:507-24.
13. Transfersomes. From Wikipedia, the free encyclopedia. Available from: http://www.en.wikipedia.org/wiki/ Transfersome. [Last accessed on 2016 May 28].
14. Cevc G, Blume G, Schatzlein A. Transferosomes mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in-vivo. J Control Release 1997; 45:211-26.
15. Cevc G, Schatzlein A, Blume G. Transdermal drug carriers: Basic properties, optimization and transfer efficiency in case of epicutaneously applied peptides. J Control Release 1995; 36:3-16.
16. Jain S, Umamaheshwari RB, Bhadra D, Tripathi P, Jain P, Jain NK. Ultra deformable liposome: A recent tool for effective transdermal drug delivery. Indian J Pharm Sci 2003; 65:223-31.
17. Kombath RV, Minumula SK, Sockalingam A, Subadhra S, Parre S, Reddy TR, et al. Criticalissues related to transfersomes - Novel vesicular system. Acta Sci Pol Technol Aliment 2012; 11:67-82.
18. Sharma N, Agarwal G, Rana AC, Bhat Z and Kumar D: A Review: Transdermal drug delivery system: A tool for novel drug delivery system. International Journal of Drug Development and Research 2011; 3:70-84.
19. Patel RP and Baria AH: Formulation and evaluation considerations of transdermal drug delivery system. International Journal of Pharmaceutical Research, 2011; 3:1-9.
20. Vinod KR, Sarvani P, Banji D and Teja BB: Transdermal drug delivery system over coming challenges of popular drug delivery system. International Journal of Pharma World Research, 2010; 1:1-14.
21. Cevc G. Isothermal lipid phase. Transitions Chemistry and Physics of Lipids 1991; 57:293-299.
22. Schatzlein A, Cevc G. Skin penetration by phospholipids vesicles, Transfersomes as visualized by means of the Confocal Scanning Laser Microscopy, in characterization, metabolism, and novel biological applications. Champaign. AOCS Press 1995; 191-209.
23. Bangham AD. Physical structure and behavior of lipids and lipid enzymes. Adv Lipid Res 1963; 1:65–104.
24. Swarnlata Saraf, Gunjan Jeswani, Chanchal Deep Kaur, Shailendra Saraf. Development of novel herbal cosmetic cream with Curcuma longa extract loaded transfersomes for anti-wrinkle effect. African J Pharm Pharmacol 2011; 5(8):1054-1062.
25. Walve J R, Bakliwal S R, Rane B R, Pawar S P. Transfersomes: a surrogated carrier for transdermal drug delivery system, Int J Applied Biology PharmaTechnol, 2011; 2(1):204-213.
26. Woo HJ, Carraro C, Chandler D. Assembly of extended interfaces and micelles: Charge frustrated models of amphiphilic mixtures. Faraday Discuss. 1996; 104:183-191.
27. Zhdanov RI, Podobed OV. Vlassov VV. Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry. 2002; 58:53.
28. Strittmatter P, Enoch HG. Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. Methods Enzymol.1978; 52:188-193.
29. Cevc G, Blume G, Sehatzlein A, Gebauer D, Paul A. The skin - A pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv 1996; 18:349-78.
30. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992; 1104:226-32.
31. Patel R, Singh SK, Singh S, Sheth NR, Gendle R. Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res 2009; 1:71-80.
32. Ashish Y. Pawar, Khanderao R. Jadhav, Laxmikant H. Chaudhari Transfersome: A Novel Technique Which Improves Transdermal Permeability. Asian Journal of Pharmaceutics • 2016; 10(4)(Suppl):S425.
33. Gregor C, Dieter G, Juliane S, Andreas S, Gabriele B. Ultra-flexible vesicles, transfer somes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biophys Acta 1998; 1368:201-15.
34. El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from lipid vesicles: Importance of liposome structure. Int J Pharm 2000; 204:159-69.
35. Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004; 270:119-25.
36. Hofer C, Göbel R, Deering P, Lehmer A, Breul J. Formulation of interleukin-2 and interferon-alpha containing ultradeformable carriers for potential transdermal application. Anticancer Res 1999; 19:1505-7.
37. Benson HA. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv 2006; 3:727-37.
38. Dubey V, Mishra D, Asthana A, Jain NK. Transdermal delivery of a pineal hormone: Melatonin via elastic liposomes. Biomaterials 2006; 27:3491-6.
39. Modi CD, Bharadia PD. Transfersomes: A newdominants for transdermal drug delivery. Am J PharmTech Res 2012; 2:71-91.
40. Nagasamy Venkatesh D, Kalyani K, Tulasi K, Swetha Priyanka V, Abid Ali SK, Kiran HC, Transfersomes: a novel technique for transdermal drug delivery International Journal of Research in Pharmaceutical and Nano Sciences. 2014; 3(4):266 – 276
41. Enhanced Transdermal delivery of indinavir sulfate via transfersomes, Sheo DM, Shweta A, Vijay KT, Ram CD, Aklavya S, Ghanshyam M, Pharmacie Globale (IJCP) 2010; 1(06):1-7
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).